Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

New Stock Coverage: Time to Go Long Tallgrass Energy?


Wall Street ratings agencies set the tone for today's stock market.

Mr. Market finally split with Ms. Ruby Tuesday after 20 straight dates, only to ultimately find love in the arms of His Girl Friday. A just-right May jobs report on the final trading session enabled shares to end in the black on the week. Not all equities shared in the exuberance, however, with language learning outfit Rosetta Stone (RST) tumbling 13.72%.

Something was certainly lost in translation when Frenchman François Hollande, speaking in Asia, had his remarks interpreted into English thus: "You must understand that the crisis in the eurozone is over." This will be news not just to his fellow countrymen, whose unemployment rate rose to a record high, but also to Athens, where National Bank of Greece (NBG) nosedived 19.24% last week to finish Friday at a record low.

No top-tier economic data due today, the start of what is quite a quiet week for such releases. On the earnings front, Annie's (BNNY), Lululemon Athletica (LULU), Navistar International (NAV), and Pep Boys – Manny, Moe & Jack (PBY) are all expected to reveal results.

Ambit Biosciences (AMBI): Shares are assigned a Buy at Citigroup.

Credit Acceptance Corp. (CAAC): Bank of America-Merrill Lynch begins Neutral-rated coverage on the company.

CST Brands (CST): Credit Suisse covers the company at a Neutral.

CVR Refining (CVRR): Goldman Sachs starts the stock at a Neutral.

Javelin Mortgage (JMI): JMI is initiated with a Buy and $21 price objective at Ladenburg Thalmann, which notes the company has enjoyed an annualized total return in excess of its peers in recent years.

Questar (STR): Shares are set a Neutral at UBS.

SunEdison (SUNE): Morgan Stanley starts shares in the semiconductor firm at an Equal-Weight.

Tallgrass Energy Partners (NYSE:TEP): The stock is picked up with a Neutral at Citi although Bank of America-Merrill Lynch (Buy), Credit Suisse (Outperform), and Stifel (Buy and $23 price target) are all more upbeat.

Vitamin Shoppe (VSI): Longbow launches Buy-rated research on the equity.

(See also: Stock Upgrades: AT&T Gets Good Reception and Stock Downgrades: Morgan Stanley May Have a Bad Case of the Mondays.)
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos